Ann: Update on BLA for Graft Versus Host Disease, page-226

How do you figure? The premise for it being down at $1.00 was WAYYYY before any such market crash. Actually its $1.00 valuation was back when the stock market was at an all time high.
It hit $1.00 way back then because there were cash raises which needed to occur (which now will again), there was no approval in sight within a 6-12 month period and there were doubts over whether MSB would ever see approval.

That exact same situation has just now occurred again except this time MSB has actually been told "NO". So I'm unsure why you think it can't reach its $1.00 levels again.

That reminds me of the people who saw the slow train down from $8.00 to $1.00. I know because I was part of that and HODL'd thought the ENTIRE THING whilst averaging down at certain points. Long story short I'm not doing it again.

Mark my words this stock is going to see the 1.00 range again unless it is saved by ARDS or something out of left field. Because that FDA approval of Ryoncil (which I think will come in time) I don't think that would occur until what 2nd quarter next year?

MSB now will not have incoming cash from its likely (or factored in) sales of Ryoncil and will require a capital raise, and that CR will be done in the worst circumstances possible (a FDA rejection).